Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith S Currier

Showing results (91-100 of 325) with videos related to

Pageof 33
Sort By:
Annals of Internal Medicine|June 28, 2021
Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 TherapeuticsLisa LaVange, Stacey J Adam, Judith S Currier, et al.
LGBT Health|September 7, 2017
Transgender Women Living with HIV Frequently Take Antiretroviral Therapy and/or Feminizing Hormone Therapy Differently Than Prescribed Due to Drug-Drug Interaction ConcernsHannan M Braun, Jury Candelario, Courtney L Hanlon, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 28, 2017
Predictors of Impaired HDL Function in HIV-1 Infected Compared to Uninfected IndividualsTheodoros Kelesidis, Michael N Oda, Mark S Borja, et al.
AIDS Research and Human Retroviruses|July 7, 2020
Short Communication: Impact of Fat Changes on the Effect of Protease Inhibitors on Lumbar Spine Bone Mineral Density Changes with Antiretroviral Therapy InitiationJoshua Garza, Carlee Moser, Douglas W Kitch, et al.
Journal of the International AIDS Society|April 29, 2017
Factors associated with retention in Option B+ in Malawi: a case control studyRisa M Hoffman, Khumbo Phiri, Julie Parent, et al.
The Journal of Infectious Diseases|June 21, 2015
Benefits of PrEP as an Adjunctive Method of HIV Prevention During Attempted Conception Between HIV-uninfected Women and HIV-infected Male PartnersRisa M Hoffman, Amber Jaycocks, Raffaele Vardavas, et al.
HIV/AIDS (Auckland, N.Z.)|November 19, 2011
Participation of women in HIV clinical trials: the IPEC-FIOCRUZ experienceJordan E Lake, Ruth K Friedman, Cynthia B Cunha, et al.
BMC Health Services Research|February 16, 2023
Experiences with telemedicine for HIV care in two federally qualified health centers in Los Angeles: a qualitative studyDaisy Walker, Corrina Moucheraud, Derrick Butler, et al.
Circulation|June 21, 2008
Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapyJudith S Currier, Jens D Lundgren, Andrew Carr, et al.
Archives of Internal Medicine|March 16, 2005
Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trialKathleen Mulligan, Robert Zackin, Rebecca A Clark, et al.
Pageof 33

Showing results (91-100 of 325) with videos related to

Sort By:
Pageof 33
Annals of Internal Medicine|June 28, 2021
Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 TherapeuticsLisa LaVange, Stacey J Adam, Judith S Currier, et al.
LGBT Health|September 7, 2017
Transgender Women Living with HIV Frequently Take Antiretroviral Therapy and/or Feminizing Hormone Therapy Differently Than Prescribed Due to Drug-Drug Interaction ConcernsHannan M Braun, Jury Candelario, Courtney L Hanlon, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 28, 2017
Predictors of Impaired HDL Function in HIV-1 Infected Compared to Uninfected IndividualsTheodoros Kelesidis, Michael N Oda, Mark S Borja, et al.
AIDS Research and Human Retroviruses|July 7, 2020
Short Communication: Impact of Fat Changes on the Effect of Protease Inhibitors on Lumbar Spine Bone Mineral Density Changes with Antiretroviral Therapy InitiationJoshua Garza, Carlee Moser, Douglas W Kitch, et al.
Journal of the International AIDS Society|April 29, 2017
Factors associated with retention in Option B+ in Malawi: a case control studyRisa M Hoffman, Khumbo Phiri, Julie Parent, et al.
The Journal of Infectious Diseases|June 21, 2015
Benefits of PrEP as an Adjunctive Method of HIV Prevention During Attempted Conception Between HIV-uninfected Women and HIV-infected Male PartnersRisa M Hoffman, Amber Jaycocks, Raffaele Vardavas, et al.
HIV/AIDS (Auckland, N.Z.)|November 19, 2011
Participation of women in HIV clinical trials: the IPEC-FIOCRUZ experienceJordan E Lake, Ruth K Friedman, Cynthia B Cunha, et al.
BMC Health Services Research|February 16, 2023
Experiences with telemedicine for HIV care in two federally qualified health centers in Los Angeles: a qualitative studyDaisy Walker, Corrina Moucheraud, Derrick Butler, et al.
Circulation|June 21, 2008
Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapyJudith S Currier, Jens D Lundgren, Andrew Carr, et al.
Archives of Internal Medicine|March 16, 2005
Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trialKathleen Mulligan, Robert Zackin, Rebecca A Clark, et al.
Pageof 33